Alirocumab (anti-PCSK9), 1mg*5

Alirocumab (anti-PCSK9), 1mg*5

Necitumumab (anti-EGFR), 1mg

Necitumumab (anti-EGFR), 1mg

Alirocumab (anti-PCSK9), 1mg*25

19.336,31 RON
SKU
SKM_A2047_1mg*25

Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Alirocumab (anti-PCSK9) works by inhibiting the PCSK9 protein, which binds to the low-density lipoprotein receptor (LDLR) and causes receptor degradation, removing less LDL cholesterol from the circulation.